ORIGINAL PAPER
Free Access
Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies
ABSTRACT
Objective
To explore the feasibility of routine maternal blood cell‐free (cf) DNA testing in screening for trisomies 21, 18 and 13 at 10 weeks' gestation.
Method
In this prospective study, women attending The Fetal Medicine Centre in London, UK, between October 2012 and April 2013, with singleton pregnancy and live fetus with CRL 32–45 mm, were screened for trisomies 21, 18 and 13 by cfDNA testing at 10 weeks and the combined test at 12 weeks.
Results
cfDNA testing was performed in 1005 singleton pregnancies with a median maternal age of 37 (range, 20–49) years. Risks for trisomies were provided for 957 (95.2%) cases and in 98.0% these were available within 14 days from sampling. In 48 (4.8%) cases no result was provided due to problems with delivery to the laboratory, low fetal fraction or assay failure. Repeat sampling was performed in 40 cases and a result obtained in 27 (67.5%) of these. In 11 cases the risk score for trisomy 21 and in five cases that for trisomy 18 was > 99%, in one the risk for trisomy 13 was 34% and in 968 the risk for each of the three trisomies was < 0.01%. The suspected trisomies were confirmed by karyotyping after chorionic villus sampling (CVS), except in one case of trisomy 18 in which the karyotype was normal. On the basis of the maternal age distribution of the study population, the expected and observed numbers for each of the three trisomies were similar. Both cfDNA and combined testing detected all trisomies, but the estimated false‐positive rates (FPR) were 0.1% and 3.4%, respectively.
Conclusion
Routine screening for trisomies 21, 18 and 13 by cfDNA testing at 10 weeks is feasible and has a lower FPR than does combined testing, but abnormal results require confirmation by CVS. Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.
Citing Literature
Number of times cited: 81
- Léon Nshimyumukiza, Jean-Alexandre Beaumont, Julie Duplantie, Sylvie Langlois, Julian Little, François Audibert, Christopher McCabe, Jean Gekas, Yves Giguère, Christian Gagné, Daniel Reinharz and François Rousseau, Cell-Free DNA–Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis, Journal of Obstetrics and Gynaecology Canada, 10.1016/j.jogc.2017.05.015, 40, 1, (48-60), (2018).
- Dong Liang, Ying Lin, Fengchang Qiao, Hang Li, Yan Wang, Jingjing Zhang, An Liu, Xiuqing Ji, Dingyuan Ma, Tao Jiang, Ping Hu and Zhengfeng Xu, Perinatal outcomes following cell‐free DNA screening in >32 000 women: Clinical follow‐up data from a single tertiary center, Prenatal Diagnosis, 38, 10, (755-764), (2018).
- M. M. Gil, M. Brik, C. Casanova, R. Martin-Alonso, M. Verdejo, E. Ramírez and B. Santacruz, Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test, The Journal of Maternal-Fetal & Neonatal Medicine, 10.1080/14767058.2016.1253062, 30, 20, (2476-2482), (2016).
- Huiying Hu, Yulin Jiang, Minghui Zhang, Shanying Liu, Na Hao, Jing Zhou, Juntao Liu, Xiaojin Zhang and Liangkun Ma, A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down’s syndrome with conventional non-invasive testing technology, Experimental Biology and Medicine, 242, 5, (547), (2017).
- Gokcen Orgul, Ozgur Ozyuncu, Ahmet Oktem and M. Sinan Beksac, Management and outcomes of cystic hygromas: experience of a tertiary center, Journal of Ultrasound, 20, 2, (127), (2017).
- Lisa Hui and Diana W. Bianchi, Noninvasive Prenatal DNA Testing: The Vanguard of Genomic Medicine, Annual Review of Medicine, 10.1146/annurev-med-072115-033220, 68, 1, (459-472), (2017).
- C. Belloin, F. Jacquemard, C. Bernabé-Dupont, G. Viot, L. Lohmann and G. Grangé, Le dépistage prénatal non invasif de la trisomie 21. Étude rétrospective à propos de 8821 patientes, La Revue Sage-Femme, 16, 4, (243), (2017).
- V. Velissariou and P.C. Patsalis, Noninvasive Cell-Free DNA Prenatal Testing for Fetal Aneuploidy in Maternal Blood, Molecular Diagnostics, 10.1016/B978-0-12-802971-8.00024-9, (423-443), (2017).
- Sylvie Langlois, JoAnn Johnson, François Audibert, Jean Gekas, Jean‐Claude Forest, André Caron, Keli Harrington, Melanie Pastuck, Hasna Meddour, Amélie Tétu, Julian Little and François Rousseau, Comparison of first‐tier cell‐free DNA screening for common aneuploidies with conventional publically funded screening, Prenatal Diagnosis, 37, 12, (1238-1244), (2017).
- Matthew R. Grace, Emily Hardisty, Sarah K. Dotters-Katz, Neeta L. Vora and Jeffrey A. Kuller, Cell-Free DNA Screening, Obstetrical & Gynecological Survey, 10.1097/OGX.0000000000000342, 71, 8, (477-487), (2016).
- C. Belloin, F. Jacquemard, C. Bernabé-Dupont, G. Viot, L. Lohmann and G. Grangé, Le dépistage prénatal non invasif de la trisomie 21. Étude rétrospective à propos de 8821 patientes, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 45, 9, (1127), (2016).
- Hagit Shani, Tamar Goldwaser, Jennifer Keating and Susan Klugman, Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center, American Journal of Obstetrics and Gynecology, 10.1016/j.ajog.2015.12.025, 214, 6, (729.e1-729.e11), (2016).
- R. Douglas Wilson, Liona C. Poon and Alessandro Ghidini, Current controversies in prenatal diagnosis 3: is there still a value in a nuchal translucency screening ultrasound in conjunction with maternal plasma non‐invasive cell‐free DNA testing?, Prenatal Diagnosis, 36, 1, (20-24), (2015).
- Emily Suskin, Laura Hercher, Kathleen Erskine Aaron and Komal Bajaj, The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice, Journal of Genetic Counseling, 25, 5, (1032), (2016).
- Lucia Rosignoli and Gabriele Tonni, Should cell‐free fetal DNA be included in first trimester screening (FTS) for common trisomy? A possible scenario on 6697 women screened over 10 years, Journal of Evaluation in Clinical Practice, 22, 6, (903-910), (2016).
- Howard Cuckle, Strategies for Implementing Cell-Free DNA Testing, Clinics in Laboratory Medicine, 10.1016/j.cll.2016.01.010, 36, 2, (213-226), (2016).
- Nicola Persico, Simona Boito, Benedetta Ischia, Adalgisa Cordisco, Valentina De Robertis, Isabella Fabietti, Enrico Periti, Paolo Volpe, Luigi Fedele and Georgios Rembouskos, Cell‐free DNA testing in the maternal blood in high‐risk pregnancies after first‐trimester combined screening, Prenatal Diagnosis, 36, 3, (232-236), (2016).
- X. Zeng, L. Zannoni, I. Löwy and S. Camporesi, Localizing NIPT: Practices and meanings of non-invasive prenatal testing in China, Italy, Brazil and the UK, Ethics, Medicine and Public Health, 2, 3, (392), (2016).
- Birgit Sikkema-Raddatz, Lennart F. Johansson, Eddy N. de Boer, Elles M. J. Boon, Ron F. Suijkerbuijk, Katelijne Bouman, Catia M. Bilardo, Morris A. Swertz, Martijn Dijkstra, Irene M. van Langen, Richard J. Sinke and Gerard J. te Meerman, NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results, Scientific Reports, 6, 1, (2016).
- Emily C. Higuchi, Jane P. Sheldon, Brian J. Zikmund‐Fisher and Beverly M. Yashar, Non‐invasive prenatal screening for trisomy 21: Consumers' perspectives, American Journal of Medical Genetics Part A, 170, 2, (375-385), (2015).
- Yuval Yaron, The implications of non‐invasive prenatal testing failures: a review of an under‐discussed phenomenon, Prenatal Diagnosis, 36, 5, (391-396), (2016).
- Li Liu, Kang Li, Xin Fu, Christopher Chung and Kang Zhang, A Forward Look At Noninvasive Prenatal Testing, Trends in Molecular Medicine, 22, 11, (958), (2016).
- P. Brady, N. Brison, K. Van Den Bogaert, T. de Ravel, H. Peeters, H. Van Esch, K. Devriendt, E. Legius and J.R. Vermeesch, Clinical implementation of NIPT – technical and biological challenges, Clinical Genetics, 89, 5, (523-530), (2015).
- M. M. Gil, R. Revello, L. C. Poon, R. Akolekar and K. H. Nicolaides, Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell‐free DNA test contingent on results from first‐trimester combined test, Ultrasound in Obstetrics & Gynecology, 47, 1, (45-52), (2015).
- L. C. Poon, D. Dumidrascu‐Diris, C. Francisco, I. Fantasia and K. H. Nicolaides, IONA test for first‐trimester detection of trisomies 21, 18 and 13, Ultrasound in Obstetrics & Gynecology, 47, 2, (184-187), (2015).
- M. M. Gil, M. S. Quezada, R. Revello, R. Akolekar and K. H. Nicolaides, Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis, Ultrasound in Obstetrics & Gynecology, 45, 3, (249-266), (2015).
- Melissa Hill and Lyn S. Chitty, Noninvasive Prenatal Screening and Diagnosis Using Cell‐free Fetal DNA, Genetic Disorders and the Fetus, (453-482), (2015).
- Wybo Dondorp, Guido de Wert, Yvonne Bombard, Diana W Bianchi, Carsten Bergmann, Pascal Borry, Lyn S Chitty, Florence Fellmann, Francesca Forzano, Alison Hall, Lidewij Henneman, Heidi C Howard, Anneke Lucassen, Kelly Ormond, Borut Peterlin, Dragica Radojkovic, Wolf Rogowski, Maria Soller, Aad Tibben, Lisbeth Tranebjærg, Carla G van El and Martina C Cornel, Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening, European Journal of Human Genetics, 23, 11, (1438), (2015).
- A. Letourneau, J.-M. Costa and A. Benachi, ADN fœtal libre dans le sang maternel, Gynécologie Obstétrique & Fertilité, 43, 2, (163), (2015).
- J I Iruretagoyena, M Grady and D Shah, Discrepancy in fetal sex assignment between cell free fetal DNA and ultrasound, Journal of Perinatology, 10.1038/jp.2014.231, 35, 3, (229-230), (2015).
- Sebastian Larion, Steven L. Warsof, Letty Romary, Margaret Mlynarczyk, David Peleg and Alfred Z. Abuhamad, Use of the Combined First‐Trimester Screen in High‐ and Low‐Risk Patient Populations After Introduction of Noninvasive Prenatal Testing, Journal of Ultrasound in Medicine, 34, 8, (1423-1428), (2015).
- Jan M. M. Van Lith, Brigitte H. W. Faas and Diana W. Bianchi, Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with low a priori risk, Prenatal Diagnosis, 35, 1, (8-14), (2015).
- E. Kalafat, M. M. Seval, B. Turgay and A. Koc, Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusion, Case Reports, 10.1136/bcr-2014-207309, 2015, jan28 1, (bcr2014207309-bcr2014207309), (2015).
- Steven L. Warsof, Sebastian Larion and Alfred Z. Abuhamad, Overview of the impact of noninvasive prenatal testing on diagnostic procedures, Prenatal Diagnosis, 35, 10, (972-979), (2015).
- Laura A. Geer, Benny F.G. Pycke, David M. Sherer, Ovadia Abulafia and Rolf U. Halden, Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology, Environmental Research, 136, (470), (2015).
- Ji Hye Kim, Gun Ho Lee, Dong Hyun Cha, Eun-Hae Cho and Yong Wook Jung, Noninvasive prenatal test for the pregnancy with Turner syndrome mosaicism 45, X/47, XXX: A case report, Journal of Genetic Medicine, 12, 2, (118), (2015).
- Carmina Comas, Mónica Echevarria, M Angeles Rodríguez, Pilar Prats, Ignacio Rodríguez and Bernat Serra, Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting, The Journal of Maternal-Fetal & Neonatal Medicine, 28, 10, (1196), (2015).
- Matthew R. Grace, Emily Hardisty, Noah S. Green, Emily Davidson, Alison M. Stuebe and Neeta L. Vora, Cell free DNA testing–interpretation of results using an online calculator, American Journal of Obstetrics and Gynecology, 213, 1, (30.e1), (2015).
- Gwendolin Manegold-Brauer, C. Berg, A. Flöck, A. Rüland, U. Gembruch and A. Geipel, Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center, Archives of Gynecology and Obstetrics, 292, 3, (543), (2015).
- Djie Tjwan Thung, Lean Beulen, Jayne Hehir-Kwa and Brigitte H Faas, Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories, Expert Review of Molecular Diagnostics, 10.1586/14737159.2015.973857, 15, 1, (111-124), (2014).
- Vincenza Precone, Valentina Del Monaco, Maria Valeria Esposito, Fatima Domenica Elisa De Palma, Anna Ruocco, Francesco Salvatore and Valeria D’Argenio, Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives, BioMed Research International, 10.1155/2015/161648, 2015, (1-15), (2015).
- Howard Cuckle, Peter Benn and Eugene Pergament, Cell-free DNA screening for fetal aneuploidy as a clinical service, Clinical Biochemistry, 48, 15, (932), (2015).
- Brandon S. Walker, Brian R. Jackson, Danielle LaGrave, Edward R. Ashwood and Robert L. Schmidt, A cost‐effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome, Prenatal Diagnosis, 35, 5, (440-446), (2015).
- H. Zhang, Y. Gao, F. Jiang, M. Fu, Y. Yuan, Y. Guo, Z. Zhu, M. Lin, Q. Liu, Z. Tian, H. Zhang, F. Chen, T. K. Lau, L. Zhao, X. Yi, Y. Yin and W. Wang, Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies, Ultrasound in Obstetrics & Gynecology, 45, 5, (530-538), (2015).
- M. S. Quezada, M. M. Gil, C. Francisco, G. Oròsz and K. H. Nicolaides, Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks, Ultrasound in Obstetrics & Gynecology, 45, 1, (36-41), (2014).
- L. Hui, M. Teoh, F. da Silva Costa, P. Ramsay, R. Palma‐Dias, Z. Richmond, S. Piessens and S. Walker, Clinical implementation of cell‐free DNA‐based aneuploidy screening: perspectives from a national audit, Ultrasound in Obstetrics & Gynecology, 45, 1, (10-15), (2015).
- M. M. Gil, G. Giunta, E. A. Macalli, L. C. Poon and K. H. Nicolaides, UK NHS pilot study on cell‐free DNA testing in screening for fetal trisomies: factors affecting uptake, Ultrasound in Obstetrics & Gynecology, 45, 1, (67-73), (2014).
- Annika Åhman, Ove Axelsson, Gordan Maras, Christine Rubertsson, Anna Sarkadi and Peter Lindgren, Ultrasonographic fetal soft markers in a low‐risk population: prevalence, association with trisomies and invasive tests, Acta Obstetricia et Gynecologica Scandinavica, 93, 4, (367-373), (2014).
- K E Pettit, A D Hull, L Korty, M C Jones and D H Pretorius, The utilization of circulating cell-free fetal DNA testing and decrease in invasive diagnostic procedures: an institutional experience, Journal of Perinatology, 10.1038/jp.2014.102, 34, 10, (750-753), (2014).
- Lawrence D. Platt, Mary Beth Janicki, Tracy Prosen, James D. Goldberg, Joseph Adashek, Reinaldo Figueroa, John Rodis, Wayne Liao, Amy J. Sehnert, Holly L. Snyder and Steven L. Warsof, Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States, American Journal of Obstetrics and Gynecology, 10.1016/j.ajog.2014.03.065, 211, 4, (368.e1-368.e7), (2014).
- Maeghan Toews and Timothy Caulfield, Physician Liability and Non-Invasive Prenatal Testing, Journal of Obstetrics and Gynaecology Canada, 36, 10, (907), (2014).
- Diana W. Bianchi, Dick Oepkes and Alessandro Ghidini, Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?, Prenatal Diagnosis, 34, 1, (6-11), (2013).
- E. Krampl-Bettelheim, Zukunft der Pränataldiagnostik, Der Gynäkologe, 47, 8, (559), (2014).
- Bjørn Hofmann, B. Hofmann svarer:, Tidsskrift for Den norske legeforening, 134, 3, (266), (2014).
- Lindsey E. Hunter and John M. Simpson, Prenatal screening for structural congenital heart disease, Nature Reviews Cardiology, 11, 6, (323), (2014).
- Gunhild Garmo Hov, Arne Åsberg and Ketil Thorstensen, Bedre spesifisitet gir mindre skade av friske fostre, Tidsskrift for Den norske legeforening, 134, 3, (266), (2014).
- Eugene Pergament, Howard Cuckle, Bernhard Zimmermann, Milena Banjevic, Styrmir Sigurjonsson, Allison Ryan, Megan P. Hall, Michael Dodd, Phil Lacroute, Melissa Stosic, Nikhil Chopra, Nathan Hunkapiller, Dennis E. Prosen, Sallie McAdoo, Zachary Demko, Asim Siddiqui, Matthew Hill and Matthew Rabinowitz, Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort, Obstetrics & Gynecology, 124, 2, PART 1, (210), (2014).
- Anthony O. Odibo and Alessandro Ghidini, Role of the second‐trimester ‘genetic sonogram’ for Down syndrome screen in the era of first‐trimester screening and noninvasive prenatal testing, Prenatal Diagnosis, 34, 6, (511-517), (2014).
- Amy J. Wagner, Michael E. Mitchell and Aoy Tomita-Mitchell, Use of Cell-Free Fetal DNA in Maternal Plasma for Noninvasive Prenatal Screening, Clinics in Perinatology, 41, 4, (957), (2014).
- Jan E. Dickinson, Noninvasive prenatal testing: Known knowns and known unknowns, Australian and New Zealand Journal of Obstetrics and Gynaecology, 54, 5, (397-399), (2014).
- Michael Morris and Christof Meyer-Kleine, Wie verlässlich ist der Nachweis fetaler Trisomien aus mütterlichem Blut?, gynäkologie + geburtshilfe, 19, 2, (22), (2014).
- Kjell Åsmund Salvesen, Fosterdiagnostikk med blodprøver, Tidsskrift for Den norske legeforening, 134, 4, (388), (2014).
- Pe'er Dar, Kirsten J. Curnow, Susan J. Gross, Megan P. Hall, Melissa Stosic, Zachary Demko, Bernhard Zimmermann, Matthew Hill, Styrmir Sigurjonsson, Allison Ryan, Milena Banjevic, Paula L. Kolacki, Susan W. Koch, Charles M. Strom, Matthew Rabinowitz and Peter Benn, Clinical experience and follow-up with large scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testing, American Journal of Obstetrics and Gynecology, 211, 5, (527.e1), (2014).
- Diana W. Bianchi, R. Lamar Parker, Jeffrey Wentworth, Rajeevi Madankumar, Craig Saffer, Anita F. Das, Joseph A. Craig, Darya I. Chudova, Patricia L. Devers, Keith W. Jones, Kelly Oliver, Richard P. Rava and Amy J. Sehnert, DNA Sequencing versus Standard Prenatal Aneuploidy Screening, New England Journal of Medicine, 370, 9, (799), (2014).
- Gwendolin Manegold-Brauer, Sinuhe Hahn and Olav Lapaire, What does next-generation sequencing mean for prenatal diagnosis?, Biomarkers in Medicine, 8, 4, (499), (2014).
- Markus Stumm, Michael Entezami, Karsten Haug, Cornelia Blank, Max Wüstemann, Bernt Schulze, Gisela Raabe‐Meyer, Maja Hempel, Markus Schelling, Eva Ostermayer, Sabine Langer‐Freitag, Tilo Burkhardt, Roland Zimmermann, Tina Schleicher, Bernd Weil, Ulrike Schöck, Patricia Smerdka, Sebastian Grömminger, Yadhu Kumar and Wera Hofmann, Diagnostic accuracy of random massively parallel sequencing for non‐invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe, Prenatal Diagnosis, 34, 2, (185-191), (2013).
- N. Okun, M. Teitelbaum, T. Huang, C. S. Dewa and J. S. Hoch, The price of performance: a cost and performance analysis of the implementation of cell‐free fetal DNA testing for Down syndrome in Ontario, Canada, Prenatal Diagnosis, 34, 4, (350-356), (2014).
- L. Hui, M. Bethune, A. Weeks, J. Kelley and L. Hayes, Repeated failed non‐invasive prenatal testing owing to low cell‐free fetal DNA fraction and increased variance in a woman with severe autoimmune disease, Ultrasound in Obstetrics & Gynecology, 44, 2, (242-243), (2014).
- W. Sepulveda, Discordant results between fetal cell‐free DNA in maternal plasma and chorionic villus sampling in a first‐trimester fetus with increased nuchal translucency and megacystis, Ultrasound in Obstetrics & Gynecology, 44, 3, (369-369), (2014).
- R. Maymon, H. Cuckle, R. Svirsky, L. Sheena, Y. Melcer, H. Rozen and I. Ben‐Ami, Nuchal translucency in twins according to mode of assisted conception and chorionicity, Ultrasound in Obstetrics & Gynecology, 44, 1, (38-43), (2014).
- T. K. Lau, S. W. Cheung, P. S. S. Lo, A. N. Pursley, M. K. Chan, F. Jiang, H. Zhang, W. Wang, L. F. J. Jong, O. K. C. Yuen, H. Y. C. Chan, W. S. K. Chan and K. W. Choy, Non‐invasive prenatal testing for fetal chromosomal abnormalities by low‐coverage whole‐genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center, Ultrasound in Obstetrics & Gynecology, 43, 3, (254-264), (2014).
- Basky Thilaganathan, Editor's Note, Ultrasound in Obstetrics & Gynecology, 43, 1, (1-2), (2014).
- Y. Gao, D. Stejskal, F. Jiang and W. Wang, False‐negative trisomy 18 non‐invasive prenatal test result due to 48,XXX,+18 placental mosaicism, Ultrasound in Obstetrics & Gynecology, 43, 4, (477-478), (2014).
- J. D. Sonek and H. S. Cuckle, What will be the role of first‐trimester ultrasound if cell‐free DNA screening for aneuploidy becomes routine?, Ultrasound in Obstetrics & Gynecology, 44, 6, (621-630), (2014).
- D. Oepkes, Y. Yaron, P. Kozlowski, M. J. Rego de Sousa, J. L. Bartha, E. S. van den Akker, S. M. Dornan, E. Krampl‐Bettelheim, M. Schmid, M. Wielgos, V. Cirigliano, G. C. Di Renzo, A. Cameron, P. Calda and A. Tabor, Counseling for non‐invasive prenatal testing (NIPT): what pregnant women may want to know, Ultrasound in Obstetrics & Gynecology, 44, 1, (1-5), (2014).
- P. Benn, H. Cuckle and E. Pergament, Non‐invasive prenatal testing for aneuploidy: current status and future prospects, Ultrasound in Obstetrics & Gynecology, 42, 1, (15-33), (2013).
- S. Yagel, Non‐invasive prenatal testing: more questions than answers, Ultrasound in Obstetrics & Gynecology, 42, 4, (369-372), (2013).
- Mylène Badeau, Carmen Lindsay, Jonatan Blais, Leon Nshimyumukiza, Yemisi Takwoingi, Sylvie Langlois, France Légaré, Yves Giguère, Alexis F Turgeon, William Witteman and François Rousseau, Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011767.pub2, (2017).
- Matthew S. Payne and Sara Bayatibojakhi, Exploring Preterm Birth as a Polymicrobial Disease: An Overview of the Uterine Microbiome, Frontiers in Immunology, 10.3389/fimmu.2014.00595, 5, (2014).
- Peter Benn, Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects, Journal of Clinical Medicine, 10.3390/jcm3020537, 3, 2, (537-565), (2014).
- Brandon S. Walker, Richard E. Nelson, Brian R. Jackson, David G. Grenache, Edward R. Ashwood, Robert L. Schmidt and Sinuhe Hahn, A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States, PLOS ONE, 10.1371/journal.pone.0131402, 10, 7, (e0131402), (2015).
